Oropharyngeal swabs increase the number of viral infections detected by 15%, compared to collection of a nasopharyngeal swab alone.

In 2021, the global Oropharyngeal Swabs for COVID-19 Testing market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Oropharyngeal Swabs for COVID-19 Testing status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Oropharyngeal Swabs for COVID-19 Testing development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Oropharyngeal Swabs for COVID-19 Testing Scope and Market Size
Oropharyngeal Swabs for COVID-19 Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oropharyngeal Swabs for COVID-19 Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nylon Fibers
Polyurethane Foam
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Roche
1 Drop Inc
SolGent Co
Abbott
PerkinElmer, Inc
Diagnostic Hybrids, Inc
Hologic
COPAN Diagnostics Inc
LabCorp
Quidel
BGI
Sansure
Liferiver Bio-Tech
Zhuhai Livzon Diagnostics Inc
Vazyme
Geneodx
Wondfo
Maccura Biotechnology Co
Wuhan Easy Diagnosis Biomedicine Co